Temporal Relationships between Pain, Mood and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 5 2 2021
medline: 16 7 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

We sought to determine the time-lagged, bidirectional relationships among clinical variables of pelvic pain, urinary symptoms, negative mood, nonpelvic pain and quality of life in men and women with urological chronic pelvic pain syndrome, incorporating interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. A total of 204 female and 166 male patients were assessed up to 24 times over a 48-week period on the 5 primary outcomes. A lagged autoregressive analysis was applied to determine the directional relationship of one variable to another 2 weeks later, beyond that of the concurrent relationships at each time point and autocorrelations and trends over time. The results show clear evidence for a bidirectional positive relationship between changes in pelvic pain severity and urinary symptom severity. Increases in either variable predicted significant increases in the other 2 weeks later, beyond that explained by their concurrent relationship at each time point. Pelvic pain and to a lesser degree urinary frequency also showed similar bidirectional relationships with negative mood and decreased quality of life. Interestingly, neither pelvic pain or urinary symptom severity showed lagged relationships with nonpelvic pain severity. Results document for the first time specific short-term positive feedback between pelvic pain and urinary symptoms, and between symptoms of urological chronic pelvic pain syndrome, mood and quality of life. The feedforward aspects of these relationships can facilitate a downward spiral of increased symptoms and worsening psychosocial function, and suggest the need for multifaceted treatments and assessment to address this possibility in individual patients.

Identifiants

pubmed: 33535797
doi: 10.1097/JU.0000000000001595
pmc: PMC9179931
mid: NIHMS1805330
doi:

Banques de données

ClinicalTrials.gov
['NCT02514265']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1698-1703

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK082345
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082315
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082316
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103227
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082344
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082333
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK082316
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK082333
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082325
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103260
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082370
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK082342
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103271
Pays : United States

Références

J Urol. 2013 Jan;189(1):141-5
pubmed: 23164386
J Urol. 2016 Nov;196(5):1450-1455
pubmed: 27131464
Urology. 1997 May;49(5A Suppl):58-63
pubmed: 9146003
Front Psychol. 2020 Apr 28;11:771
pubmed: 32411053
J Urol. 2011 Jun;185(6):2162-70
pubmed: 21497847
BMC Urol. 2014 Aug 01;14:58
pubmed: 25085119
Clin J Pain. 2020 Jan;36(1):8-15
pubmed: 31794439
JAMA. 1999 Jul 21;282(3):236-7
pubmed: 10422990
Urology. 2009 Nov;74(5):983-7, quiz 987.e1-3
pubmed: 19800663
J Urol. 2017 Oct;198(4):848-857
pubmed: 28528930
Transl Androl Urol. 2015 Oct;4(5):524-33
pubmed: 26813921
BMC Urol. 2014 Aug 01;14:57
pubmed: 25085007
Urology. 2015 Jun;85(6):1319-27
pubmed: 26099876
Can Urol Assoc J. 2018 Jun;12(6(Suppl3)):S145
pubmed: 29875052
J Urol. 2017 Sep;198(3):622-631
pubmed: 28373134
J Urol. 2016 Apr;195(4 Pt 1):949-54
pubmed: 26585679
Neurourol Urodyn. 2018 Mar;37(3):926-941
pubmed: 28990698
Nat Rev Urol. 2019 Mar;16(3):187-200
pubmed: 30560936
J Med Internet Res. 2007 Jan 31;9(1):e2
pubmed: 17478411
J Urol. 2015 May;193(5):1554-8
pubmed: 25463989

Auteurs

Bruce D Naliboff (BD)

University of California Los Angeles, Los Angeles, California.

Andrew D Schrepf (AD)

University of Michigan, Ann Arbor, Michigan.

Alisa J Stephens-Shields (AJ)

University of Pennsylvania, Philadelphia, Pennsylvania.

J Quentin Clemens (JQ)

University of Michigan, Ann Arbor, Michigan.

Michael A Pontari (MA)

Temple University, Philadelphia, Pennsylvania.

Jennifer Labus (J)

University of California Los Angeles, Los Angeles, California.

Bayley J Taple (BJ)

Northwestern University, Evanston, Illinois.

Larissa V Rodriguez (LV)

University of Southern California, Los Angeles, California.

Eric Strachan (E)

University of Washington, Seattle, Washington.

James W Griffith (JW)

Northwestern University, Evanston, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH